معرفی
Dr. Emma Lidington is a Postdoctoral Research Associate in Cancer Behavioural Science at Queen Mary University of London's Wolfson Institute of Population Health. Her research focuses on using behavioral science to improve cancer prevention trial participation and assess the psychological impact of new screening programs. She holds a PhD in psychobiology and public health, emphasizing the care experiences and supportive care needs of young adults with cancer. Previously, she worked at the Royal Marsden NHS Foundation Trust as a trial manager, implementing digital patient-reported outcome systems. She currently serves as Publications Editor for the EORTC Quality of Life Group.
Research Interests:
- Psychological impact and acceptability of new cancer screening tests (e.g., bladder cancer urine kits, oesophageal sponge tests)
- Barriers/facilitators to screening uptake
- Use of patient-reported outcomes (PROs) in clinical trials and routine care
- Inclusivity in cancer screening trials, particularly for underrepresented groups
Professional Contributions:
- Editorial role in EORTC Quality of Life Group publications
- Development of digital tools for patient support in breast cancer trials
Grants & Advising: No formal grants or advisee students listed, though her work involves collaborative research projects funded by EORTC and NIHR initiatives. She actively contributes to multidisciplinary teams in trial design and outcome measure development.
